Evidence map›Paper›PMID 42523320›Full record

ArticlebioRxiv : the preprint server for biology2026

Differential Metabolite Production Underlies Disruption of the Cystic Fibrosis Airway Microbiota by Pathogens.

Sydney M Morabbi, Niladri Bhowmik, Shaz Sutherland, Evelyn A Wylie, Reagan S Decker, Akram Al Daerwish, Mercedes Pérez Pérez, Elizabeth Pascual, Erika I Lutter, Benjamin Philmus and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sydney M MorabbiDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Niladri BhowmikDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Shaz SutherlandDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331.
Evelyn A WylieDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Reagan S DeckerDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Akram Al DaerwishDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Mercedes Pérez PérezDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Elizabeth PascualDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.
Erika I LutterDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.ORCID 0000-0002-1953-2467
Benjamin PhilmusDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon 97331.ORCID 0000-0003-2085-0873
Reed M StubbendieckDepartment of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, OK 74078.ORCID 0000-0003-1507-3272

Funding

The adolescent microbiome-gut-brain axis as a potential target in opioid abuse disordersP20GM152333 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI Crystal Nicole Johnson · 2024 to 2026
$8.7M
Research Training in Natural Product Complementary and Integrative Health - Diversity Supplement to T32 Predoctoral Training GrantT32AT010131 · NCCIH · OREGON STATE UNIVERSITY · PI TAIFO MAHMUD, RICHARD B VAN BREEMEN · 2020 to 2026
$1.8M
NCCIH NIH HHS T32 AT010131NIGMS NIH HHS P20 GM152333
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a multisystem disease characterized by the accumulation of mucus in the airways that promotes pathogen colonization, leading to respiratory exacerbations, lung failure, and death. Culture-independent approaches have revealed that the CF airway harbors a complex microbiota, including opportunistic pathogens and bacteria that colonize the oropharynx. Here, we reanalyzed 5,260 16S rRNA gene microbiota datasets to infer ecological associations between members of the CF microbiota. We determined that pathogens are more likely to proliferate and dominate when present, while oropharyngeal bacteria are more likely to form persistent communities. Further, we found higher diversity and increasing numbers of inferred interactions were positively associated with lung function. In contrast, pathogens were negatively associated both with each other and with oropharyngeal bacteria, suggesting that they may disrupt the microbiota. To validate these predictions, we cultured 1,597 bacterial isolates from 96 people with CF and performed 12,542 coculture assays against eight representative CF pathogenic and oropharyngeal bacteria. 23% of these interactions resulted in growth inhibition. While

Indexed as

antagonismcystic fibrosislung microbiomemicrobial ecologymicrobial interactionsnatural productsPseudomonas aeruginosasecondary metabolites

Identifiers

PMID42523320
PMCPMC13405137

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.